OBJECTIVE： To explore appropriate pharmaceutical care methods for hemophilia children， and to improve rational drug use. METHODS： Drug consultation hemophilia records collected from our hospital during Nov. 2014 to Jul. 2015 were summarized in respects of personal structure， form and content； key cases were analyzed specially. RESULTS： During Nov. 2014-Jul. 2015， clinical pharmacists received 130 times/cases of medication consultation that related to hemophilia in our hospital； patient’s family members occupied the main part （70.0％）； most of drug consultation form was information platform for consultation （58.5％）； consultation content mainly covered drug combination and auxiliary medication （77.7％）. Clinical pharmacists have reduced the risk of bleeding， improved the quality of life， reduced the economic burden of families and strengthened the awareness of medical staff and patient’s family member on safe drug use through finding out medication error timely， paying attention to the component of compound drug， guiding medication direction and optimizing therapy plan. CONCLUSIONS： Clinical pharmacists actively provide pharmaceutical care and promote rational drug use during hemophilia treatment from medication consultation， rational drug use， etc.